The PDA Aseptic Manufacturing Excellence Conference 2025 (13–14 October, Melbourne) will be a premier gathering for professionals shaping the future of aseptic manufacturing. The event will bring together regulators, industry leaders, and innovators to explore how organisations can align with evolving international standards while adopting new technologies to strengthen sterility assurance and operational excellence.
Over two content-rich days, delegates will gain insights into the TGA’s adoption of PIC/S PE009-17, practical strategies for Annex 1 implementation, and effective approaches to contamination control. Case studies from Pfizer, CSL, and ANSTO will highlight advances in facility qualification, biologics and vaccine manufacturing, and emerging quality control methods, including rapid mycoplasma detection, recombinant Factor C endotoxin testing, and automated environmental monitoring.
Regulatory perspectives from the TGA and APVMA will ensure participants are well-prepared for compliance, complemented by sessions on container closure integrity, cleanroom management, and Quality Risk Management. Expert panels will also address critical industry topics such as PUPSIT, fostering open dialogue between regulators and manufacturers.
SeerPharma is proud to contribute to the program. Louise White, Director and APVMA Auditor, will deliver a session on APVMA GMP compliance, addressing the regulatory framework, inspection practices, and sterile-specific requirements such as cleanroom classification, environmental monitoring, aseptic process simulations, sterilisation validation, and data integrity. The session will also examine common inspection findings and provide practical strategies to support compliance and inspection readiness.
In addition, Jo Sherriff, SeerPharma’s Engineering Compliance Manager, will chair a panel of experts covering:
- Cleaning classified rooms to meet EU Annex 1 requirements
- Dispelling myths in GMP
- Emerging expectations in aseptic processing
Alongside its strong technical agenda, the conference offers valuable networking opportunities with peers across the industry. With its emphasis on regulatory alignment, innovation, and best practice, this event is a must-attend forum for those seeking to enhance sterility assurance and achieve manufacturing excellence in an increasingly complex environment.
For more information and to register, please visit: PDA Aseptic Manufacturing Excellence Conference 2025
At SeerPharma, we are proud to share our expertise at leading industry events—another way we continue to “Advance Quality and GMP Best Practices in the Asia-Pacific region”.
